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Abstract: 
Myosin II (MyoII) is required for insulin-responsive glucose transporter 4 (GLUT4)-mediated 
glucose uptake in 3T3-L1 adipocytes. Our previous studies have shown that insulin signaling 
stimulates phosphorylation of the regulatory light chain (RLC) of MyoIIA via myosin light chain 
kinase (MLCK). The experiments described here delineate upstream regulators of MLCK during 
insulin-stimulated glucose uptake. Since 3T3-L1 adipocytes express two MyoII isoforms, we 
wanted to determine which isoform was required for insulin-stimulated glucose uptake. Using a 
siRNA approach, we demonstrate that a 60% decrease in MyoIIA protein expression resulted in 
a 40% inhibition of insulin-stimulated glucose uptake. We also show that insulin signaling 
stimulates the phosphorylation of MLCK. We further show that MLCK can be activated by 
calcium as well as signaling pathways. We demonstrate that adipocytes treated with the calcium 
chelating agent, 1,2-b (iso-aminophenoxy) ethane-N,N,N',N'-tetra acetic acid, (BAPTA) (in the 
presence of insulin) impaired the insulin-induced phosphorylation of MLCK by 52% and the 
RLC of MyoIIA by 45% as well as impairing the recruitment of MyoIIA to the plasma 
membrane when compared to cells treated with insulin alone. We further show that the calcium 
ionophore, A23187 alone stimulated the phosphorylation of MLCK and the RLC associated with 
MyoIIA to the same extent as insulin. To identify signaling pathways that might regulate MLCK, 
we examined ERK and CaMKII. Inhibition of ERK2 impaired phosphorylation of MLCK and 
insulin-stimulated glucose uptake. In contrast, while inhibition of CaMKII did inhibit 
phosphorylation of the RLC associated with MyoIIA, inhibition of CAMKIIδ did not impair 
MLCK phosphorylation or translocation to the plasma membrane or glucose uptake. 
Collectively, our results are the first to delineate a role for calcium and ERK in the activation of 
MLCK and thus MyoIIA during insulin-stimulated glucose uptake in 3T3-L1 adipocytes. 
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Introduction 
A critical component of whole body glucose homeostasis is insulin-stimulated glucose uptake 
into adipose tissue and skeletal muscle [1]. Insulin stimulates glucose uptake by inducing the 
translocation, docking and fusion of the insulin responsive glucose transporter 4 (GLUT4) to the 
plasma membrane. Insulin-stimulated glucose uptake requires the activation of several signaling 
pathways to mediate the trafficking of GLUT4 vesicles from an intracellular pool to their fusion 
with the plasma membrane [2]. The binding of insulin to its receptor activates the 
phosphatidylinositol-3 kinase (PI3K), mitogen activated protein kinase (MAPK), Cbl and 
Ca2+signaling pathways [3]–[6]. All of these pathways are required for GLUT4 trafficking and 
glucose uptake in adipocytes. 
While insulin does not cause dramatic changes in intracellular Ca2+ levels, Ca2+ is required for 
insulin-stimulated glucose uptake. Previous studies have shown that Ca2+ plays a role in two 
steps in insulin-stimulated glucose uptake [5], [6]. Chelating intracellular Ca2+ results in impaired 
GLUT4 vesicle translocation and fusion with the plasma membrane [5], [6]. Insight into a potential 
mechanism of action of Ca2+ in GLUT4 vesicle trafficking comes from the known function of 
Ca2+ in other exocytic processes (reviewed in [7]). Ca2+ has been shown to be required for 
GLUT4 vesicle fusion with the plasma membrane [8]. Vesicle fusion requires actin reorganization 
and the regulation of other cytoskeletal structures at the cell cortex. While filamentous actin (F-
actin) reorganization has also been implicated in GLUT4 trafficking and insulin-stimulated 
glucose uptake [9] little is known about the contractile activities/forces involved in regulating 
actin reorganization. 
Mature adipocytes do not have an extensive array of stress fibers but instead have a layer of 
cortical actin filaments that line the inner surface of the plasma membrane [10]. Previous studies 
have demonstrated that insulin-stimulated GLUT4 translocation and membrane fusion in 
adipocytes requires cortical actin reorganization [9]. In adipocytes the actin cytoskeleton 
functions as a barrier (or shell) at the cell cortex which must be “loosened/relaxed” in order for 
vesicles to fuse with the plasma membrane. To accomplish this function the actin cytoskeleton 
requires the myosin family of actin-based motor proteins. Members of the myosin family have 
been shown to contract actin filaments [11]. Contraction of the acto-myosin cytoskeleton can lead 
to the localized membrane remodeling required for vesicle fusion at the plasma membrane. 
The myosin responsible for actin filament contraction is ‘conventional’ myosin, myosin II, 
(MyoII) [11]. Nonmuscle cells express MyoII isoforms that function in a manner similar to their 
muscle counterpart. In contrast to skeletal muscle MyoII, which is organized in a highly regular 
and stable arrangement with actin filaments in sarcomeres, nonmuscle MyoII can undergo 
dramatic changes in localization and activation as a part of various cellular events (reviewed 
in[12]). Previous studies have implicated a role for nonmuscle MyoII in vesicle transport and 
fusion [13]. These studies suggest that there are distinct zones at the cell cortex where myosin-
dependent cytoskeletal reorganization occurs and allows for the localized membrane remodeling 
required for vesicle fusion with the plasma membrane. Previous studies have shown that MyoII 
plays a similar role in the GLUT4 vesicle trafficking required for insulin-stimulated glucose 
uptake [14]–[17]. 
Nonmuscle MyoII is a hexameric protein consisting of two heavy chains (MHC), two regulatory 
light chains (RLC) and two essential light chains (ELC) [11]. MyoII motor activity and parallel 
filament assembly are regulated by the phosphorylation of residues localized on the RLCs [11]. 
Phosphorylation of the RLC via myosin light chain kinase (MLCK) initiates the binding of 
MyoII to filamentous actin [18]–[20]. Our previous studies show that insulin specifically stimulates 
the phosphorylation of the RLC associated with the MyoIIA isoform via MLCK but not by 
RhoK [14]. In time course experiments, we determined that GLUT4 translocates to the plasma 
membrane independently of prior to MyoIIA recruitment [16]. We further show that recruitment 
of MyoIIA to the plasma membrane requires that MyoIIA be activated via phosphorylation of the 
RLC by MLCK [16], [17]. While MyoII activity is not required for GLUT4 translocation it is 
required for proper GLUT4-vesicle fusion at the plasma membrane [16]. What is not known is the 
mechanism by which MLCK is regulated during insulin-stimulated glucose uptake. MLCK can 
be activated by both a Ca+2-dependent and -independent manner. Increased levels of intracellular 
Ca+2 coupled with calmodulin activate MLCK resulting in the phosphorylation of the RLC of 
MyoII [21]. MLCK can also be activated by the MAPK (RAS/Raf/MEK/ERK) pathway in a Ca+2- 
independent manner [22], [23]. Both ERK and CaMKII have been shown to regulate MLCK 
phosphorylation in a variety of cellular processes [22]–[24]. 
In the present study we examined the mechanism by which insulin signaling mediates MLCK 
phosphorylation and thus MyoIIA and GLUT4-mediated glucose uptake in adipocytes. Our 
results reveal that insulin signaling via elevated levels of Ca+2 and the MAPK pathway activate 
MLCK via phosphorylation during insulin-stimulated glucose uptake. Thus our studies are the 
first to identify the insulin induced regulators of MLCK required for activation of MyoIIA and 
insulin-stimulated glucose uptake in adipocytes. 
Materials and Methods 
Materials 
Tissue culture reagents were purchased from Gibco (Grand Island, NY). Insulin was obtained 
from Roche Diagnostics Corporation (Indianapolis, IN). Dexamethasone, 3-isobytyl-1-methyl-
xanthine, 1,2-Bis (2-aminophenoxy) ethane-N,N,N′,N′-tetraacetic acid tetrakis (acetoxymethyl 
ester) (BAPTA) and myosin IIA antibody were purchased from Sigma (St. Louis, MO). A-23187 
and 1-[N,O-bis-(5-Isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine(KN-62) were 
purchased from Calbiochem (San Diego, CA). U-0126 was from Promega (Madison, WI). 
Myosin light chain (phosphor S20) antibody was purchased from Abcam (Cambridge, MA). 
GLUT4 antibodies (C-20 and N-20), MLCK antibody and protein A/G plus agarose beads were 
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Phospho-MLCK antibody was from 
Invitrogen (Carlsbad, CA). The myosin IIA and IIB antibodies were obtained from Covance 
(Berkeley, CA). Actin, phospho-myosin light chain (Thr 18/Ser 19) antibody, ERK1/2 and 
pERK1/2 antibodies were obtained from Cell Signaling (Danvers, MA). CaMKII delta antibody 
was a generous gift from Dr. Harold Singer (Albany Medical College, NY). Alexa Fluor® 594 
donkey anti-goat IgG and Alexa Fluor 488 goat anti-rabbit IgG were from Molecular Probes, Inc. 
(Eugene, OR). The enhanced chemiluminescence (ECL) detection kit and horseradish peroxidase 
conjugated secondary antibodies were obtained from Amersham Bioscience (Piscataway, NJ). 
Cell Culture 
3T3-L1 fibroblasts were obtained from the ATCC (Manassas, VA). Cells were grown to 
confluency and then induced to differentiate in 10% Fetal Bovine Serum (FBS)/Dulbecco's 
Modified Eagle Media (DMEM) with the addition of 0.52 mM 3-isobutyl 1-methyl-xanthine 
(MIX), 1.7 µM insulin, and 1 µM dexamethasone (DEX) on Day 0. On Day 2, the media was 
changed to 10%FBS/DMEM plus 0.425 µM insulin. The media was replaced with DMEM 
containing 10% FBS every two days [25], [26]. 
siRNA Duplexes 
The siRNA (Dharmacon, Inc., Lafayette, CO) for myosin IIA, IIB, MLCK, CaMKIIδ, ERK2 or a 
scrambled sequence was ON-TARGET plus Smart POOL. 
Electroporation 
Day 8 3T3-L1 adipocytes were washed with a 1X PBS and solubilized using 0.5% trypsin-
EDTA. After a 6 min incubation at 37°C, cells were resuspended in 10% FBS/DMEM and 
centrifuged for 5 min at 100×g. The supernatant was removed and the cells were resuspended in 
1× PBS and centrifuged for 5 min at 100×g twice. The cell pellet was resuspended in 1 ml 
1×PBS per 15 cm plate used. Cuvettes (4 mm gap) containing 1 nmol of the siRNA (water, 
Myosin IIA, Myosin IIB, Scramble, MLCK, CaMKIIδ, or ERK2) were placed on ice. Cells 
(2.5×106) along with the 1 nmol of siRNA was electroporated at 0.18 kV and 975 microfarads 
using a Bio-Rad Gene Pulser II. Immediately after electroporation, cells were re-suspended in 
8.5 ml of 10%FBS/DMEM. After a 10 minute incubation period at 25°C, cells were re-plated 
onto multi-well plates. After 24 h, media was replaced with 10% FBS/DMEM [27]–[29]. 
Glucose uptake assay 
3T3-L1 preadipocytes were induced to differentiate as described above. Glucose uptake assays 
were performed on fully mature 3T3-L1 adipocytes. Adipocytes were serum-starved for 4 h in 
the presence of 0.1% DMSO (Basal) or inhibitor as indicated. Adipocytes were washed twice 
with 37°C Krebs Ringer Phosphate (KRP) buffer (pH 7.4) containing 128 mM NaCl, 4.7 mM 
KCl, 1.65 mM CaCl2, 2.5 mM MgSO4, 5 mM Na2HPO4 and then placed in KRP buffer 
containing vehicle, 50 µM BAPTA-AM, 0.1 µM A23187, 25 µM U0126 or 100 µM KN-62 as 
indicated. Adipocytes were then either untreated (basal) or treated with insulin (100 nM) for 10 
min, followed by [1-14C]-2-deoxy-D-glucose (0.1 µCi/well) (NEN) and 5 mM glucose for an 
additional 10 min at 37°C. Cells were washed three times with phosphate buffered saline (PBS) 
and solubilized in 0.5 M NaOH and 0.1% SDS. Samples were assayed for 14C-2-deoxy-D-
glucose uptake as disintegrations per min per mg protein. Data are expressed as means ± SEM. 
Immunoblot analysis 
Cells were lysed in a buffer containing 25 mM HEPES pH 7.4, 1% Nonidet P-40, 100 mM NaCl, 
2% glycerol, 5 mM NaF, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaPPi, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml aprotinin, 5 mg/ml leupeptin, and 5 mg/ml 
pepstatin [9]. Cell lysates were incubated at 4°C for 20 min and then centrifuged at 6,000×g for 
20 min at 4°C. Supernatants (100 µg) were incubated for 5 minutes at 95°C in Laemmli sample 
buffer [30], and then subjected to SDS-PAGE. Proteins were transferred to Immobilon-P 
membranes (Millipore), and analyzed by immunoblotting as previously described [31]. Protein 
bands were quantified by densitometry using ImageQuant (version 5.2 for Windows) software. 
Immunoprecipitation 
Whole cell lysates (1 mg) were incubated with antibodies (3 µg/ml) overnight at 4°C. Protein 
A/G PLUS–agarose beads were added to the immunoprecipitates and incubated for 1 h at 4°C. 
Samples were subjected to centrifugation at 2500×g and then washed three times with ice cold 
lysis buffer. Immunoprecipitated proteins were dissolved in 5× Laemmli buffer and then 
subjected to SDS-PAGE and immunoblot analysis. 
Immunofluorescence 
Adipocytes grown on coverslips were serum starved for 4 h and treated according to the glucose 
uptake protocol (omitting 14C-2-DOG). Cells were fixed with 3% buffered paraformaldehyde, 
and then permeablized in 0.25% triton X-100 for 5 min at 4°C. Cells were incubated with anti-
GLUT4 antibody or anti-myosin IIA antibody. The cells were then incubated with the 
appropriate secondary labeled antibodies. Slides were viewed using an Olympus IX81 Motorized 
Inverted Confocal Microscope and FLUOVIEW FV5OO software. The relative intensity of 
immunofluroescence was quantified using Image-Pro Plus software (Silver Spring, MD). 
Statistical analysis 
Results are expressed as mean ± SEM. Statistical significance was determined using unpaired 
Student's t test, with P<0.05 considered significant. 
Results 
Inhibition of MyoIIA alone impairs insulin-stimulated glucose uptake 
Our previous studies using pharmacological inhibitors demonstrated that inhibition of myosin II 
resulted in impaired insulin-stimulated glucose uptake in 3T3-L1 adipocytes [16]. Since 3T3-L1 
adipocytes express both myosin II isoforms, IIA and IIB, it is important to determine the role of 
each of the isoforms during insulin-stimulated glucose uptake. Since pharmacological inhibitors 
are not specific, we wanted to use a siRNA approach to determine which MyoII isoform was 
involved in insulin-stimulated glucose uptake. Fully differentiated adipocytes were 
electroporated with either vehicle or with siRNA (Scramble, MyoIIA, or MyoIIB). After 72 h 
cells were serum starved for 4 h and then either left untreated or stimulated with 100 nM insulin 
for 20 min. Western blots were performed to determine knockdown of the target protein in 
relation to actin. Cells electroporated with either vehicle or scrambled sequence had similar 
levels of MyoIIA and MyoIIB (Fig. 1A). In contrast, adipocytes electroporated with siRNA 
targeting MyoIIA had a 60% reduction in MyoIIA protein expression (Fig. 1A and B) and had no 
effect on MyoIIB protein levels when compared to vehicle-treated or scrambled siRNA 
electroporated cells. However, adipocytes electroporated with siRNA targeting MyoIIB had a 
50% reduction in MyoIIB protein levels but also knocked down the expression of the myosin IIA 
by 50% (Fig. 1A and B). 
Our previous studies have shown that the myosin IIA isoform is involved in insulin-stimulated 
glucose uptake [14], [16]. In order to determine the effect of knockdown of the myosin II isoforms 
on glucose transport we performed glucose uptake assays. Adipocytes electroporated with 
siRNA (Scramble, MyoIIA, or MyoIIB) were serum starved for 4 h and then either left untreated 
(−) or stimulated with 100 nM insulin (+) for 20 min in the presence of [1-14C]-2-deoxy-D-
glucose and glucose uptake assays were performed. There was no effect on glucose uptake under 
basal conditions with the knockdown of either myosin IIA or IIB compared to cells 
electroporated with the scramble sequence. Insulin typically stimulates glucose uptake 
approximately five to ten-fold over basal levels. In adipocytes electroporated with a scrambled 
sequence, insulin stimulated an eight-fold increase in glucose uptake over basal levels (Fig. 1C). 
Insulin-stimulated glucose uptake was decreased by approximately 40% (7.9±0.90 versus 
4.9±0.89, p<0.05) for MyoIIA knockdown cells as compared to cells electroporated with the 
scramble siRNA. There was also approximately a 40% decrease (7.9±0.90 versus 4.8±1.20, 
p<0.05) in insulin-stimulated glucose uptake in cells electroporated with MyoIIB siRNA when 
compared to cells electroporated with the scramble siRNA, however as observed from the 
western blot analysis, both MyoIIB and MyoIIA protein levels were knocked down in these cells 
making these results less conclusive. These studies suggest that knockdown of MyoIIA results in 
impaired insulin-stimulated glucose uptake and that knockdown of both MyoIIA and MyoIIB did 
not further impair glucose uptake. Thus, these finding provide further support that myosin IIA 
activity is required for insulin-stimulated glucose uptake. 
Insulin stimulates the phosphorylation of MLCK in 3T3-L1 adipocytes 
MyoII activity is regulated by the phosphorylation of residues localized on the RLCs [11],[18]–[20]. 
Our previous studies have shown that insulin specifically stimulates the phosphorylation of the 
RLC associated with the MyoIIA isoform via MLCK [16]. Inhibition of MLCK results in 
decreased phosphorylation of the RLC associated with MyoIIA and impaired insulin-stimulated 
glucose uptake [16]. In order to determine the mechanism by which the insulin signaling pathway 
regulates MLCK, we examined the phosphorylation status of the MLCK upon insulin 
stimulation. Previous studies have shown that MLCK activity is regulated by phosphorylation at 
Ser1760 [32]–[34]. Using a phospho-MLCK (Ser1760) specific antibody we observed that in the 
basal state only a low level of phospho-MLCK (p-MLCK) was detected in whole cell lysates 
(Fig. 2A). Upon insulin stimulation, there was a 4-fold increase in the level of p-MLCK (Fig. 
2B). Our results also showed that the differences in the levels of p-MLCK were due to the degree 
of phosphorylation and not the levels of total MLCK since the absolute levels of MLCK were 
unchanged under all conditions (Fig. 2). 
Calcium regulation of MLCK facilitates GLUT4-mediated glucose uptake in 3T3-L1 adipocytes 
In order to further delineate the signaling pathway(s) regulating MLCK during insulin-stimulated 
glucose uptake, we examined the role of calcium since previous studies have shown that MLCK 
is a Ca2+-regulated kinase and that inhibition of Ca2+ signaling impairs insulin-stimulated glucose 
uptake [21]–[24]. We wanted to determine whether insulin regulates MLCK in a Ca2+-dependent 
manner and reciprocally, whether Ca2+ can activate MLCK independently of insulin stimulation, 
so we employed the calcium chelator BAPTA-AM and the calcium ionophore A23187. Previous 
studies have shown that chelation of intracellular Ca2+, using BAPTA-AM significantly impaired 
insulin-stimulated glucose in 3T3-L1 adipocytes [5], [6]. In order to determine whether 
Ca2+ signaling regulates MLCK, mature 3T3-L1 adipocytes were subjected to either 50 µM 
BAPTA-AM or 0.1 µM A23187 for 20 min and then either left untreated or stimulated with 
insulin (100 nM) for an additional 20 min and assayed for glucose uptake, phosphorylation of 
MLCK, MyoIIA activation via phosphorylation of the RLC and MyoIIA localization as well as 
GLUT4 vesicle trafficking. 
As shown previously, insulin stimulated approximately a five-fold increase in glucose uptake 
over basal levels (Fig. 3A). BAPTA-AM treatment completely prevented insulin-stimulated 
glucose uptake (Fig. 3A, INS versus BAPTA-AM, 5.4±0.61 versus 1.1±0.15, p<0.05). Glucose 
uptake was decreased to basal levels in adipocytes treated with BAPTA-AM in the presence of 
insulin. BAPTA-AM treatment also decreased phosphorylation of MLCK as well as the RLC 
associated with MyoIIA (Fig. 3B and C). Since our previous studies demonstrated that 
phosphorylation of the RLC of MyoIIA is required for MyoIIA translocation to the plasma 
membrane, we examined the localization of MyoIIA and GLUT4 (Fig. 3D). As shown 
previously, BAPTA-AM decreased the translocation of GLUT4 to the plasma membrane (Fig. 
3D, panel i). BAPTA-AM also impaired MyoIIA translocation to the plasma membrane (Fig. 
3D, panel j). Both GLUT4 and MyoIIA colocalized primarily in the cytoplasm in BAPTA-AM 
treated adipocytes (Fig. 3D panel l, arrows). 
Next we wanted to determine whether increased levels of intracellular Ca2+ alone could induce 
MLCK phosphorylation as well as MyoIIA activity and recruitment to the plasma membrane in 
the absence of insulin stimulation. As expected, adipocytes treated with the calcium ionophore, 
A23187 alone did not stimulate glucose uptake (INS versus A23187, 5.4±0.61 versus 1.1±0.28, 
p<0.05) and also did not enhance glucose uptake in the presence of insulin (Fig. 3A). A23187 
alone did induce phosphorylation of MLCK as well as the RLC associated with MyoIIA (Fig. 3B 
and C). Since MLCK activation is required for the translocation of MyoIIA we wanted to 
determine if elevated Ca2+ levels alone were sufficient to induce translocation. Upon treatment 
with A23187 (in the absence of insulin) MyoIIA translocated to the plasma membrane (Fig. 3D, 
panel n). A23187 was not sufficient to induce translocation of GLUT4 in the absence of insulin 
(Fig. 3D, panel m). These findings suggest that Ca2+ alone is able to stimulate the 
phosphorylation of MLCK which in turn phosphorylates and translocates MyoIIA to the plasma 
membrane (Fig. 3D, panel o and p, arrow indicating plasma membrane localization of MyoIIA 
only). 
ERK is required for MLCK phosphorylation during insulin stimulation 
In order to determine whether there are other insulin-activated signaling pathways regulating 
MLCK phosphorylation, we wanted to examine known upstream regulators of MLCK. Both 
extracellular-signal regulated kinase (ERK) and calcium/calmodulin-dependent kinase II 
(CamKII) have been shown to be involved in insulin-stimulated glucose uptake as well as 
phosphorylation MLCK [3]–[6], [21]–[24]. To determine whether the insulin-induced phosphorylation 
of the MLCK was also due to either of these kinases we used both chemical inhibitors and 
targeted siRNA to assay for MLCK phosphorylation, glucose uptake and MyoIIA and GLUT4 
localization. 
Insulin stimulates ERK1/2 though activation of the RAS, Raf, MEK cascade. MEK is an 
immediate upstream activator of ERK1/2. The MEK inhibitor, U0126, not only decreases 
phosphorylation of ERK1/2 but also impairs insulin-stimulated glucose uptake in adipocytes[4]. 
ERK is also involved in the activation of MyoII. Previous studies have shown that in the 
presence of a constitutively active MEK there is an increase in phosphorylation of ERK1/2, 
MLCK, and RLC [35]. ERK1/2 has also been shown to directly phosphorylate MLCK initiating 
its activation [35]. To determine if ERK is required for the activation of MLCK during insulin-
stimulated glucose uptake in adipocytes, we treated adipocytes with U0126 in the presence of 
insulin to examine the effect on glucose uptake and MyoIIA localization. In agreement with 
previous studies we show that U0126 impairs insulin-stimulated glucose uptake (Fig. 4A, Ins 
versus U0126, 8.3±0.98 versus 4.5±0.49, p<0.05) [4]. Inhibition of ERK1/2 also impaired both 
GLUT4 and MyoIIA from translocating to the plasma membrane upon insulin stimulation (Fig. 
3D, panels q and r). Both GLUT4 and MyoIIA colocalized within the cytoplasm (Fig. 3D, panels 
s and t, arrow indicating colocalization in the cytoplasm). Since inhibition of ERK prevented 
translocation of MyoIIA, we wanted to determine both if ERK acts by regulating MLCK 
(inhibition of MLCK also impairs MyoIIA translocation) and which isoform of ERK was 
responsible for this regulation. In a previous study ERK2 alone was found to induce 
phosphorylation of MLCK and that in the absence of MLCK ERK2 was unable to phosphorylate 
RLC [35]. These findings suggest that ERK2 activates MLCK which then mediates the 
phosphorylation of RLC of MyoIIA. To examine the role of ERK2 in MLCK phosphorylation, 
we electroporated adipocytes with siRNA targeting ERK2 and then assayed for ERK2 
expression, MLCK phosphorylation and glucose uptake. As shown by immunoblot analysis 
ERK2 levels were markedly reduced following siRNA treatment in comparison to ERK2 protein 
levels in cells electroporated with a scramble siRNA (Fig. 4B and C). Reduction in ERK2 
proteins levels had no effect on the protein levels of ERK1 (Fig. 4B). In addition, our results 
show that insulin-stimulated phosphorylation of MLCK was markedly reduced in cells 
electroporated with ERK2 siRNA compared to that of cells electroporated with a scramble 
sequence (Fig. 4B and C). This suggests that ERK2 is an upstream activator of MLCK. Next, we 
wanted to determine the impact the reduced level of ERK2 would have on insulin-stimulated 
glucose uptake in the adipocytes. Figure 4D revealed no noticeable difference in the basal levels 
of glucose uptake into the cells with reduced levels of ERK2 compared to the control. However, 
under insulin-stimulated conditions, ERK2 deficient cells had approximately a 30% decrease in 
glucose uptake compared to cells electroporated with the scramble sequence (Fig, 4D, 6.4±0.66 
versus 4.1±0.11, p<0.05). These results suggest a role for ERK2 in the regulation of MLCK and 
thus MyoIIA during insulin-stimulated glucose uptake in the adipocyte. 
CaMKII is required for MLCK phosphorylation during insulin stimulation 
Inhibitor studies, using the CaMKII inhibitor, KN62, have implicated a role for CaMKII in 
insulin-stimulated glucose transport [36], [37]. CaMKII has multiples substrates, and it has been 
suggested to play a role in the regulation of both MLCK and ERK [38], [39]. What is not known is 
whether insulin stimulates MLCK and MyoIIA phosphorylation via the CaMKII pathway. To 
determine if CaMKII plays a role in the activation of MyoIIA, we treated adipocytes with the 
CaMKII inhibitor, KN-62 in the presence of insulin. Our studies show that KN-62 decreased 
insulin-stimulated glucose uptake by approximately 50% when compared to untreated cells (Fig. 
5A, 8.3±0.97 versus 3.7±1.14, p<0.05). We next examined if inhibition of CaMKII impaired 
phosphorylation of the RLC of MyoIIA. Adipocytes treated with KN-62 in the presence of 
insulin had a 60% decrease in the levels of p-RLC associated with MyoIIA compared to levels in 
untreated cells (Fig. 5B, 3.6±0.22 versus 1.4±0.23, p<0.05). 
A previous study examining the unconventional myosin, myosin IC (MyoIC) in adipocytes 
found that CaMKIIδ was able to phosphorylate MyoIC in vitro and subsequently activate its 
ATPase activity [37]. Thus we wanted to determine if CaMKIIδ was the CaMKII isoform 
regulating MLCK, and thus MyoIIA during insulin-stimulated glucose uptake. 3T3-L1 
adipocytes were electroporated with siRNA targeting CaMKIIδ. After 72 h, cell lysates were 
collected and subjected to SDS-PAGE and immunoblot analysis. Our results show that there was 
a reduced level of CaMKIIδ expression in adipocytes electroporated with CaMKIIδ siRNA 
compared to those with the scramble sequence (Fig. 5C and D). We also observed that MLCK 
phosphorylation was not inhibited upon insulin stimulation in cells with CaMKIIδ siRNA and 
the levels were similar to those in cells treated with a scramble siRNA (Fig. 5C and D). To 
investigate if CaMKIIδ plays a role in insulin-stimulated glucose uptake, we assayed cells 
electroporated with a scramble sequence as well as cells electroporated with CaMKIIδ siRNA. 
As seen in Fig. 5E reduced levels of CaMKIIδ had no effect on glucose uptake under basal or 
insulin-stimulated conditions which suggests that while CaMKII is involved in MLCK-mediated 
glucose uptake, the CaMKIIδ isoform is not involved in insulin-stimulated glucose uptake in 
3T3-L1 adipocytes. 
Discussion 
Previous studies have demonstrated a role for members of the myosin family in GLUT4 
trafficking [15]–[17], [40]–[44]. Myosin family members have been shown to traffic GLUT4 vesicles 
and to interact with components of the membrane docking and fusion machinery [16],[17], [41], [44]. 
Previous studies have shown a critical role for MyoII in GLUT4-mediated glucose uptake in 
adipocytes REF [14]–[17]. Since adipocytes express both MyoIIA and IIB, we wanted to determine 
the role of each in insulin-stimulated glucose uptake. While previous studies have used chemical 
inhibition, these inhibitors do not allow for the distinction between the two isoforms [16]. 
Although, more recently, the role of MyoIIA in insulin-stimulated glucose uptake was examined, 
it did not determine if MyoIIB also contributes to glucose uptake [17]. To better understand the 
role of the different MyoII isoforms we knocked down expression of both using siRNA. Our 
results reveal that only inhibition of MyoIIA through the use of an isoform-specific siRNA 
resulted in impaired insulin-stimulated glucose uptake. We were unable to knockdown MyoIIB 
without decreasing the expression of MyoIIA also. However since inhibition of both MyoIIA and 
IIB did not result in any further decrease in insulin-stimulated glucose when compared to 
inhibition of MyoIIA alone, then these findings suggest that only MyoIIA is involved in insulin-
stimulated glucose uptake. 
Previous studies have shown that MyoIIA is regulated by the phosphorylation of its RLC by 
MLCK [15], [16]. While our studies show that insulin signaling stimulates the phosphorylation of 
MLCK on Ser1760, a site that has been shown to increase its activity, other studies suggest that 
insulin is not phosphorylating MLCK via the PI3K pathway [32]–[34]. To determine the pathway(s) 
responsible for phosphorylating MLCK during insulin-stimulated glucose uptake, we examined 
pathways that were involved in both MLCK phosphorylation and insulin signaling. Three such 
signaling pathways that may function independently or in combination are calcium signaling and 
the MAPK and CaMKII pathways. Insulin is known to regulate calcium levels as well as the 
MAPK and CaMKII pathways, both of which are required for GLUT4-mediated glucose 
uptake [4]–[6]. Our studies demonstrate that calcium regulates MLCK and MyoIIA 
phosphorylation, MyoIIA translocation to the plasma membrane and insulin stimulated glucose 
uptake. Our studies are the first to show that BAPTA-AM (a calcium chelator) impaired MLCK 
phosphorylation and that calcium alone was able to phosphorylate MLCK in the absence of 
insulin (Fig. 3). These studies also demonstrated that calcium alone was sufficient to induce the 
translocation of MyoIIA to the membrane in the absence of insulin. 
Insulin also activates multiple signaling pathways to facilitate GLUT4 trafficking and insulin-
stimulated glucose uptake. The MAPK pathway has also been linked to insulin-stimulated 
glucose uptake but the downstream targets have not been identified [4]. Both ERK1 and 2 are able 
to directly phosphorylate MLCK which leads to increased phosphorylation of the RLC of 
MyoII [35]. Previous studies linking an inhibition of ERK2 to reduced levels of insulin-stimulated 
glucose uptake and GLUT4 translocation in muscle cells led us to examine the role of ERK2 in 
the phosphorylation of MLCK [45]. Our results reveal that chemical inhibition of MEK impaired 
insulin-stimulated glucose uptake by 50% in comparison to control levels. We were also able to 
show that ERK2 knockdown resulted in a decrease in insulin-stimulated phosphorylation of 
MLCK and also impaired insulin-stimulated glucose uptake. The reduced level of ERK2 resulted 
in a decrease in MLCK phosphorylation. Furthermore, confocal microscopy studies 
demonstrated that inhibition of ERK impaired MyoIIA translocation to the plasma membrane 
upon insulin stimulation. 
Another signaling pathway regulating insulin-stimulated glucose uptake is the CaMKII 
pathway[39], [46]. CaMKII is a Ca2+-dependent kinase with multiple substrates which include 
ERK2 and MLCK [38], [39]. CaMKII has four isoforms with most cells expressing at least one 
(38). In this study the CaMKIIδ isoform was targeted for a possible role in insulin-stimulated 
glucose uptake due to its expression in adipocytes and its ability to phosphorylate MyoIC in vitro 
and subsequently activates its ATPase activity [43]. We investigated the possibility that CaMKIIδ 
could phosphorylate MLCK and thus the RLC of MyoIIA. Our results revealed that knockdown 
of the CaMKIIδ isoform did not inhibit insulin-stimulated glucose uptake in 3T3-L1 adipocytes 
or MLCK phosphorylation. One possible explanation of the discrepancy between these studies is 
that Toyoda et al. achieved a 90% reduction in CaMKIIδ expression and used a higher 
concentration of siRNA then that used in this study. It is possible that this greater reduction of 
CaMKIIδ protein levels was required to affect glucose uptake, while the modest reduction of 
CaMKIIδ expression in this study was not sufficient to inhibit MLCK phosphorylation or 
glucose uptake. 
While our studies did not implicate CaMKIIδ in MyoIIA phosphorylation and glucose uptake, 
we did show that inhibition of CaMKII with chemical inhibitors did impair insulin-stimulated 
glucose uptake and phosphorylation of the RLC associated with MyoIIA. What is known is 
which CaMKII isoform is involved in MyoIIA regulation. Recent studies have implicated a role 
for CaMKII in ERK activation [24]. Studies using endothelial cells expressing a constitutively 
active CaMKII resulted in a significant increase in ERK activity (38, 45). Phosphorylation of 
ERK in these cells was inhibited by the CaMKII inhibitor, KN-62, and the MEK inhibitor U-
0126 (38, 45). Furthermore ERK phosphorylation was inhibited in the absence of activated 
CaMKII (38, 45). Other studies using CaMKII inhibitors have shown a decrease in 
phosphorylation of ERK in smooth muscle cells and endothelial cells (39, 45). However, in a 
recent paper that showed chemical inhibition of CaMKII resulted in a decrease in phosphorylated 
ERK; they were not able to find a subsequent reduction in RLC phosphorylation (45). Our 
studies implicate a possible scenario in which insulin signaling increases intracellular Ca2+ levels 
which activates a CamKII-ERK2-MLCK-RLC/MyoIIA cascade to regulate insertion of GLUT4 
vesicles at the plasma membrane during insulin-stimulated glucose uptake in adipocytes. These 
results are similar to those reported in a recent study showing that translocation of Aquaporin-1 
in renal proximal tubules also involved an ERK-MLCK-RLC/MyoII cascade [47]. However, these 
studies did not implicate calcium or CaMKII in the activation of this signaling cascade. 
In summary, our studies show that MLCK activation requires both, an increase in intracellular 
Ca+2 and activation of ERK to phosphorylate and translocate MyoIIA to the plasma membrane to 
facilitate insulin-stimulated glucose uptake. We also show that while these effects are mediated 
by insulin, Ca+2 alone is sufficient to phosphorylate MLCK and thus MyoIIA. Our results also 
demonstrate that while CaMKIIδ regulates other myosin family members, it does not stimulate 
phosphorylation of either MLCK or MyoIIA upon insulin stimulation. Collectively, our studies 
have elucidated the insulin-induced signaling components required for MLCK and MyoIIA 
activation necessary for GLUT4-mediated glucose uptake. Our findings further elucidate the role 
of cytoskeletal components involved in insulin-stimulated glucose uptake and provide further 
insight on the cellular mechanisms regulating GLUT4 trafficking. 
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